8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2015 / Randomized crossover trial
Sixteen male team-sport athletes consumed nitrate-rich or nitrate-depleted beetroot juice for 7 days in a randomized crossover study before undergoing an intermittent sprint test with concurrent cognitive tasks. Total sprint work was greater with nitrate supplementation (123 ± 19 kJ) than with placebo (119 ± 17 kJ; P < 0.05). In addition, cognitive reaction time in the second half of testing improved with nitrate juice compared to placebo (P < 0.05), with no difference observed in response accuracy.
Thompson C, Wylie LJ, Fulford J, et al. Eur J Appl Physiol, 2015. PMID 25846114
2015 / Randomized controlled trial
An 8-week randomized double-blind placebo-controlled trial evaluated 43 adult patients with major depressive disorder receiving citalopram with either vitamin C (n=21) or placebo (n=22). Although depression scores declined in both arms, the difference between groups was not statistically significant (P = .5). Remission rates, response rates, and adverse effects showed no significant differences between the vitamin C and placebo groups.
Sahraian A, Ghanizadeh A, Kazemeini F Trials, 2015. PMID 25873303
2015 / Randomized controlled trial
In a six-week trial, older adults aged over 60 consumed either two cups of frozen blueberries daily or a carrot-based control beverage. Compared with the control drink, blueberry supplementation led to significant reductions in step errors during a challenging dual-task adaptive gait assessment. Within the blueberry cohort, participants also showed significant gains in usual walking pace, single-task step accuracy, and dual-task movement speed.
Schrager MA, Hilton J, Gould R, et al. Appl Physiol Nutr Metab, 2015. PMID 25909473
2015 / Interventional study
An 8-week alternate day fasting (ADF) protocol was tested in 59 obese subjects, with food provided on fast days. Body weight decreased by 4.2 ± 0.3% (P < 0.0001). Adverse events reported included constipation (17%), water retention (2%), dizziness (<20%), general weakness (<15%), and non-significantly increased bad breath (14% to 29%). Depression and binge eating decreased (P < 0.01), restrictive eating increased (P < 0.01), body image improved (P < 0.01), and purgative behavior and fear of fatness were unchanged.
Hoddy KK, Kroeger CM, Trepanowski JF, et al. Nutr J, 2015. PMID 25943396
2015 / 12-week double-blind placebo-controlled randomized trial
A 12-week double-blind, placebo-controlled trial evaluated maca root (3.0 g/day) in 45 female outpatients with remitted depression and SSRI/SNRI-induced sexual dysfunction, with 42 eligible for modified intent-to-treat analysis. Remission rates at the end of treatment were higher with maca than placebo for an ASEX score ≤ 10 (9.5% vs. 4.8%), an MGH-SFQ score ≤ 12 (30.0% vs. 20.0%), and an MGH-SFQ score ≤ 8 (9.5% vs. 5.0%). Higher remission rates with maca compared to placebo were associated with postmenopausal status. Maca was reported to be well tolerated.
Dording CM, Schettler PJ, Dalton ED, et al. Evid Based Complement Alternat Med, 2015. PMID 25954318
2015 / Randomized controlled trial
In a randomized, placebo-controlled trial, 40 healthy adults drank either placebo or 450 mL of nitrate-rich beetroot juice (~5.5 mmol nitrate). Near-infrared spectroscopy monitored prefrontal cortex cerebral blood flow throughout 54 minutes of cognitive testing following a 90-minute absorption period. Beetroot juice modulated cerebral hemodynamics across tasks and improved performance on the serial 3s subtraction task.
Wightman EL, Haskell-Ramsay CF, Thompson KG, et al. Physiol Behav, 2015. PMID 26037632
2015 / Comparative crossover trial
Seventeen Japanese adult females viewed a kiwifruit orchard landscape or a building site (control) for 10 minutes. Compared with viewing the building site, viewing the orchard landscape resulted in a significant increase in parasympathetic activity, a marginally significant decrease in heart rate, a significant increase in 'comfortable', 'relaxed', and 'natural' feelings, and a significant improvement in mood states.
Igarashi M, Miwa M, Ikei H, et al. Int J Environ Res Public Health, 2015. PMID 26110331
2015 / Randomized controlled trial
In an ancillary trial within AREDS2, 3,501 older adults at risk for late age-related macular degeneration were randomized to receive omega-3 polyunsaturated fatty acids, lutein/zeaxanthin, both, or placebo. Over five years, yearly change in composite cognitive test scores did not differ between the fatty acid group (-0.19; 99% CI, -0.25 to -0.13) and control (-0.18; 99% CI, -0.24 to -0.12; P = .63). Similarly, lutein/zeaxanthin showed no difference compared to placebo (P = .66).
Chew EY, Clemons TE, Agrón E, et al. JAMA, 2015. PMID 26305649
2015 / Randomised, double-blind, placebo-controlled, parallel-groups study
In a randomised, double-blind, placebo-controlled study, 60 adults aged 18 to 30 years were given resveratrol or placebo for 28 days. Resveratrol modulated cerebral blood flow (CBF) parameters on day 1 as assessed by near-IR spectroscopy and significantly lowered subjective ratings of fatigue across the entire 28 days. Cognitive effects were limited to more accurate but slower serial subtraction performance on day 1, and improved 3-Back task accuracy before dose on day 28. Resveratrol significantly increased diastolic blood pressure on day 28 and resulted in higher resveratrol metabolite levels on day 28 compared with day 1.
Wightman EL, Haskell-Ramsay CF, Reay JL, et al. Br J Nutr, 2015. PMID 26344014
2015 / Randomized, double-blind, placebo-controlled trial
In a randomized trial, 42 high school students received either 500 mg per day of vitamin C or a placebo for 14 days. Supplementation significantly decreased anxiety levels on the Beck Anxiety Inventory and increased plasma vitamin C concentrations compared to placebo. A significant difference in mean heart rate was also observed between groups.
de Oliveira IJ, de Souza VV, Motta V, et al. Pak J Biol Sci, 2015. PMID 26353411
2015 / Randomized controlled trial
Twenty-four elderly patients diagnosed with depression were randomly divided into an experimental group practicing Nordic walking and a control group practicing normal walking. Both groups exercised for 50 minutes per day, three times per week for eight weeks. Both groups showed significant improvements in depression over time, with significant differences over time between groups for depression, sleep, and skeletal muscle mass.
Park SD, Yu SH J Phys Ther Sci, 2015. PMID 26357429
2015 / Randomized, double-blind, placebo-controlled phase 2 trial
In a 52-week phase 2 trial, 119 participants with mild to moderate Alzheimer disease were randomized to placebo or oral resveratrol (dose-escalated from 500 mg daily to 1,000 mg twice daily). Resveratrol and its major metabolites penetrated the blood-brain barrier. The most frequent adverse events were nausea, diarrhea, and weight loss. CSF Aβ40 and plasma Aβ40 levels declined more in the placebo group than in the resveratrol group, producing a significant difference at week 52, while brain volume loss was increased with resveratrol compared to placebo.
Turner RS, Thomas RG, Craft S, et al. Neurology, 2015. PMID 26362286
2015 / Interventional study
College students (N=122) self-monitored their eating behaviors for 96 hours, including a 24-hour fasting period, to examine the impact of short-term fasting on pathological eating patterns. Participants did not demonstrate significant increases in disordered eating behaviors following the fast, including objective binge episodes, self-defined excessive eating, or compensatory behavior use. However, baseline disinhibition predicted excessive eating and objective binge episodes both before and after fasting.
Schaumberg K, Anderson DA, Reilly EE, et al. Eat Behav, 2015. PMID 26431904
2014 / Double-blinded randomized clinical trial
In a double-blind trial, 100 individuals experiencing acute migraine without aura were randomized to receive ginger powder or sumatriptan. Two hours after administration, both treatments significantly lowered headache severity with similar efficacy. Ginger powder produced fewer clinical side effects than sumatriptan, while patient satisfaction and willingness to continue therapy were comparable after one month.
Maghbooli M, Golipour F, Moghimi Esfandabadi A, et al. Phytother Res, 2014. PMID 23657930
2014 / Three-arm intervention trial
Participants trying to reduce chocolate intake (n = 137) were allocated to use cognitive defusion, acceptance, or relaxation (control) techniques over 5 days while carrying a bag of chocolates and logging their intake. Compared to controls, participants using cognitive defusion ate significantly less chocolate from the bag (p = .046) and less chocolate based on diaries (p = .053), with evidence linking this to reduced automaticity of chocolate consumption. No differences in chocolate consumption were found between the acceptance and control groups.
Jenkins KT, Tapper K Br J Health Psychol, 2014. PMID 23678870
2014 / Randomized controlled trial
Healthy adults aged >=50 years were randomly assigned to exercise (n=47), MBSR (n=51), or a waitlist control condition (n=51) and received trivalent inactivated influenza vaccine after 6 weeks. No differences in vaccine responses were found between the control group and the MBSR or exercise groups. However, individuals achieving seroprotective antibody levels (>=160 units) had higher optimism, less anxiety, and lower perceived stress, while age correlated with antibody responses.
Hayney MS, Coe CL, Muller D, et al. Hum Vaccin Immunother, 2014. PMID 24096366
2014 / Randomized controlled trial
A clinical trial randomized 105 cognitively intact adults aged 65 to 85 years to receive either the NT-020 nutraceutical (n=52) or placebo (n=53) for two months. Participants receiving the supplement showed significant improvements on two tests of processing speed compared to the placebo group. Scores across five other evaluated cognitive areas did not differ between treatment groups, and adverse event rates were similar.
Small BJ, Rawson KS, Martin C, et al. Rejuvenation Res, 2014. PMID 24134194
2014 / Randomized controlled trial
A randomized trial assigned 48 children aged 3 to 10 years with autism to receive 200 mg daily of DHA or placebo for 6 months. Despite a median 431% surge in total plasma DHA, core autism symptoms on the Clinical Global Impressions-Improvement scale did not differ between cohorts. Parents reported superior social skills in the placebo group (P = 0.04), whereas teachers reported better functional communication with DHA (P = 0.02).
Voigt RG, Mellon MW, Katusic SK, et al. J Pediatr Gastroenterol Nutr, 2014. PMID 24345834
2014 / Counterbalanced Latin square crossover experimental study
Forty-seven healthy college students completed four breathing patterns combining two rates (6 and 5.5 breaths per minute) and two inhalation-to-exhalation ratios (5:5 and 4:6) using a counterbalanced Latin square design. A breathing pattern of 5.5 breaths per minute with an inhalation-to-exhalation ratio of 5:5 yielded a higher NN interval standard deviation and higher low frequency power than the other patterns. Additionally, all four breathing patterns significantly increased feelings of relaxation compared with baseline.
Lin IM, Tai LY, Fan SY Int J Psychophysiol, 2014. PMID 24380741
2014 / Double-blind, placebo-controlled randomized clinical trial
A randomized trial investigated the effects of 2000 IU/d of alpha tocopherol, 20 mg/d of memantine, their combination, or placebo in 613 patients with mild to moderate Alzheimer disease over a mean follow-up of 2.27 years. Over follow-up, ADCS-ADL scores declined by 3.15 units less in the alpha tocopherol group compared with placebo (95% CI, 0.92 to 5.39; adjusted P = .03), corresponding to an annualized 19% delay in clinical progression. Decline in the memantine group was not significantly different from placebo (1.98 units less; 95% CI, -0.24 to 4.20; adjusted P = .40), nor were significant differences seen for combination therapy. Caregiver time increased least with alpha tocopherol, while serious adverse events for infections or infestations were higher in the memantine and combination groups compared with placebo.
Dysken MW, Sano M, Asthana S, et al. JAMA, 2014. PMID 24381967
2014 / Randomized controlled trial
A randomized trial evaluated 270 pregnant women receiving 400 mg/day DHA or placebo from 16 weeks gestation to delivery. Infants in the placebo group had increased risk of poorer language scores at 14 months (words understood OR 3.22, CL 1.49-6.94; words produced OR 2.61, CL 1.22-5.58) and 18 months, as well as lower visual acuity at 2 months (OR 2.69, CL 1.10-6.54).
NANO counterpoint →
Mulder KA, King DJ, Innis SM PLoS One, 2014. PMID 24427279
2014 / Randomized crossover trial
Twenty-five young, healthy adults consumed 355 mL of Red Bull or water in a crossover protocol. Red Bull intake increased systolic and diastolic blood pressure (p < 0.005), heart rate, and cardiac output (p < 0.05), while elevating myocardial load and cerebrovascular resistance (p < 0.005). The energy drink also caused significant drops in end-tidal carbon dioxide levels and the speed of cerebral blood flow (p < 0.005).
Grasser EK, Yepuri G, Dulloo AG, et al. Eur J Nutr, 2014. PMID 24474552
2014 / Randomized controlled trial
This study compared the efficacy of two-week mindfulness-based interventions targeting different combinations of mindfulness skills (awareness, acceptance, disidentification) against an active control intervention (distraction) for reducing chocolate cravings. Disidentification was the most efficacious skill; participants trained in disidentification reported less intense state cravings following a craving induction task compared to those trained in distraction. This effect was mediated by an increase in disidentification skill and a subsequent decrease in trait chocolate cravings.
Lacaille J, Ly J, Zacchia N, et al. Appetite, 2014. PMID 24503333
2014 / Randomized controlled trial
Mothers were randomly allocated to receive 800 mg DHA/d or placebo from ~20 weeks of gestation until birth, and 158 term-born children completed assessments at a mean of 27 ± 2 months. There was no effect of supplementation on primary outcomes, including distractibility (mean difference: -0.2 s; 95% CI: -0.7, 0.4 s) and WMIC (mean difference: 8.9 mm; 95% CI: -10.6, 28.3 mm). Treatment children looked away from toys fewer times with competing toys but less accurately remembered a repeated hiding location, which was not consistent with other outcomes and may have been due to chance.
Gould JF, Makrides M, Colombo J, et al. Am J Clin Nutr, 2014. PMID 24522442